NexGel, Inc Common Stock (NXGL)

Price$0.59

Value ScoreA

Growth ScoreC

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-78.89%

Price vs S&P 500 (4W)-1.70%

VGM Score54.45

Market Capitalization$7.03M

All Metrics

Book Value / Share (Quarterly)$0.47

P/TBV (Annual)4.57x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)77.28%

Cash Flow / Share (Quarterly)$-0.18

Price vs S&P 500 (YTD)-73.66%

Gross Margin (TTM)38.89%

Net Profit Margin (TTM)-28.59%

EPS (TTM)$-0.40

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-0.40

Revenue Growth (5Y)76.33%

EPS (Annual)$-0.38

ROI (Annual)-56.03%

Gross Margin (Annual)39.48%

Net Profit Margin (5Y Avg)-130.20%

Cash / Share (Quarterly)$0.02

Revenue Growth QoQ (YoY)-5.56%

ROA (Last FY)-28.68%

Revenue Growth TTM (YoY)10.14%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)-57.86%

Operating Margin (TTM)-29.96%

Cash Flow / Share (Annual)$-0.17

P/B Ratio1.76x

P/B Ratio (Quarterly)1.34x

Net Income / Employee (Annual)$-157,900

EV / Revenue (TTM)0.80x

Net Interest Coverage (TTM)-84.09x

ROA (TTM)-29.68%

EPS Incl Extra (Annual)$-0.38

Current Ratio (Annual)1.47x

Quick Ratio (Quarterly)0.84x

3-Month Avg Trading Volume0.29M

52-Week Price Return-72.85%

Revenue / Employee (TTM)$592,800

Tangible BV / Share (Quarterly)$0.39

P/S Ratio (Annual)0.62x

Asset Turnover (Annual)1.09x

52-Week High$2.89

Operating Margin (5Y Avg)-94.86%

EPS Excl Extra (Annual)$-0.38

CapEx CAGR (5Y)-26.17%

26-Week Price Return-62.96%

Quick Ratio (Annual)0.59x

13-Week Price Return-49.99%

Total Debt / Equity (Annual)0.20x

Current Ratio (Quarterly)1.70x

Enterprise Value$8.99M

Revenue / Share Growth (5Y)64.61%

Asset Turnover (TTM)1.04x

Revenue / Employee (Annual)$601,100

Inventory Turnover (Annual)3.58x

Pretax Margin (Annual)-25.33%

Cash / Share (Annual)$0.04

3-Month Return Std Dev130.73%

Gross Margin (5Y Avg)19.92%

Net Income / Employee (TTM)$-169,500

ROE (Last FY)-67.28%

Net Interest Coverage (Annual)-36.52x

EPS Basic Excl Extra (Annual)$-0.38

Receivables Turnover (TTM)14.19x

Total Debt / Equity (Quarterly)0.54x

EPS Incl Extra (TTM)$-0.40

Receivables Turnover (Annual)14.22x

ROI (TTM)-55.31%

P/S Ratio (TTM)0.62x

Pretax Margin (5Y Avg)-130.59%

Revenue / Share (Annual)$1.45

Tangible BV / Share (Annual)$0.46

Forward P/E1.10x

Price vs S&P 500 (52W)-101.05%

Year-to-Date Return-62.73%

5-Day Price Return11.13%

EPS Normalized (Annual)$-0.38

ROA (5Y Avg)-32.30%

Net Profit Margin (Annual)-26.27%

Month-to-Date Return1.68%

Cash Flow / Share (TTM)$-0.45

EBITD / Share (Annual)$-0.31

Operating Margin (Annual)-27.93%

LT Debt / Equity (Annual)0.11x

ROI (5Y Avg)-50.24%

LT Debt / Equity (Quarterly)0.44x

EPS Basic Excl Extra (TTM)$-0.40

P/TBV (Quarterly)1.61x

P/B Ratio (Annual)3.87x

Inventory Turnover (TTM)3.35x

Pretax Margin (TTM)-27.40%

Book Value / Share (Annual)$0.55

Price vs S&P 500 (13W)-59.74%

Beta0.73x

Revenue / Share (TTM)$1.37

ROE (TTM)-70.35%

52-Week Low$0.48

vGradeA

gGradeC

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.11est. -0.07

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
NXGLNexGel, Inc Common Stock	A	C	D	$0.59
SYKStryker Corporation	C	C	D	$299.46
MMM3M Company	C	F	C	$150.93
BSXBoston Scientific Corp.	C	B	F	$47.98
MDLNMedline Inc. Class A common stock	C	D	D	$35.75
BDXBecton, Dickinson and Co.	B	C	C	$145.33
DXCMDexCom, Inc.	C	B	C	$74.87
RMDResMed Inc.	B	B	D	$186.44
WSTWest Pharmaceutical Services, Inc.	D	C	B	$316.30
SOLVSolventum Corporation	C	D	C	$75.84
PENPenumbra, Inc.	F	C	C	$318.95

About

NexGel Inc manufactures aqueous polymer hydrogels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics applications. The company differentiates through proprietary manufacturing technologies, including electron beam cross-linking, that enable specialized custom gel development.